Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on X:
“Reflecting back on ASCO25 I keep thinking that in oncology we have rare opportunities to celebrate and thankfully DeLLphi-304 was one of them!
So grateful to this wonderful team of researchers and collaborators involved from phase 1 of Tarlatamab up to registration”
Read OncoDaily’s special “20 Posts Not to Miss from ASCO 2025“.